Comparison of schisandrin and schisandrin B in rat serum and plasma after ig Compound Wurenchun Capsules
- VernacularTitle:大鼠灌胃复方五仁醇胶囊后血清和血浆中五味子醇甲和五味子乙素的比较
- Author:
Lin LUO
;
Zhihua DOU
;
Anwei DING
;
Lujun WANG
;
Bing ZHANG
;
Zhong SHI
- Publication Type:Journal Article
- Keywords:
Compound Wurenchun Capsules;
schisandrin;
schisandrin B;
serum containing drug;
plasma containing drug;
HPLC
- From:
Chinese Traditional and Herbal Drugs
1994;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the content of main constituents of Compound Wurenchun Capsules dissolved in serum and plasma of rats. Methods Serum and plasma containing drug were prepared after ig the preparation to rats. Lichrosphere C_ 18 (250 mm?4.6 mm, 5 ?m) column and Phenomenex Description C_ 18 (4.0 mm?3.0 mm) protective column were used. The mobile phase consisted of methanol-water, eluted in gradient mode. The flow rate was 1.0 mL/min. The column temperature was 30 ℃ and detection wavelength was 254 nm. Results The linear ranges of schisandrin and schisandrin B were 0.051 2 .614 4 and 0.039 8—0.477 6 ?g. The average relative recoveries of schinsandrin and schisandrin B were 96.72%, 101.06%, 102.05%, and 99.03%, 100.18%, 100.28% in low, middle, and high concentrations, respectively. The average contents of schisandrin in serum and plasma were 11.063 2 and 12.883 7 ?g/mL, schisandrin B were 7.490 9 and 12.590 8 ?g/mL, respectively. Conclusion The main constitu-ents of Compound Wurenchun Capsules contained in plasma account for higher than the ones in serum.
